Literature DB >> 18376363

Oxidative stress: a radical way to stop making bile.

Marcelo G Roma1, Enrique J Sanchez Pozzi.   

Abstract

Oxidative stress is a common feature in most hepatopathies. In recent years, evidence has accumulated that reactive oxygen species (ROS) induce a number of functional changes either deleterious or adaptive in the capability of the hepatocytes to produce bile and to secrete exogenous and endogenous compounds. This review is aimed to describe the mechanisms involved in these alterations. For this purpose, we will summarize: 1) The current evidence that acutely-induced oxidative stress is cholestatic, by describing the mechanisms underlying the hepatocyte secretory failure, including the disorganization of the actin cytoskeleton and its most noticeable consequences, the impairment of tight-junctional structures and the endocytic internalization of canalicular transporters relevant to bile formation. 2) The role for oxidative-stress-activated signalling pathways in the pathomechanisms described above, particularly those involving Ca2+ elevation and its consequent activation of Ca2+ -dependent PKC isoforms. 3) The mechanisms involved in the adaptive response against oxidative stress mediated by ROS-responsive transcription factors, involving up-regulation of GSH-synthesizing enzymes, GSH-detoxifying enzymes and the hepatocellular efflux pumps; this response enhances the co-coordinated inactivation by GSH conjugation of lipid peroxides and their further cellular extrusion. 4) The manner this adaptive response can be surpassed by the sustained production of ROS, thus inducing transcriptional and posttranscriptional changes in transporters relevant to bile formation, as has been shown to occur, for example, after long-term administration of aluminum to rats, in the Long-Evans Cinnamon rat (a model of chronic hepatic copper accumulation mimicking Wilson's disease), and in ischemia-reperfusion injury.

Entities:  

Mesh:

Year:  2008        PMID: 18376363

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  13 in total

1.  Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress.

Authors:  Luis E Gomez-Quiroz; Daekwan Seo; Yun-Han Lee; Mitsuteru Kitade; Timo Gaiser; Matthew Gillen; Seung-Bum Lee; Ma Concepcion Gutierrez-Ruiz; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson; Jens U Marquardt
Journal:  Toxicology       Date:  2016-07-06       Impact factor: 4.221

2.  Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes.

Authors:  Pamela Bachour-El Azzi; Ahmad Sharanek; Audrey Burban; Ruoya Li; Rémy Le Guével; Ziad Abdel-Razzak; Bruno Stieger; Christiane Guguen-Guillouzo; André Guillouzo
Journal:  Toxicol Sci       Date:  2015-02-17       Impact factor: 4.849

3.  Nuclear Factor, Erythroid 2-Like 2 Regulates Expression of Type 3 Inositol 1,4,5-Trisphosphate Receptor and Calcium Signaling in Cholangiocytes.

Authors:  Jittima Weerachayaphorn; Maria Jimena Amaya; Carlo Spirli; Piyachat Chansela; Kisha A Mitchell-Richards; Meenakshisundaram Ananthanarayanan; Michael H Nathanson
Journal:  Gastroenterology       Date:  2015-03-18       Impact factor: 22.682

Review 4.  Dynamic localization of hepatocellular transporters in health and disease.

Authors:  Marcelo G Roma; Fernando A Crocenzi; Aldo D Mottino
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

5.  Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells.

Authors:  Ahmad Sharanek; Pamela Bachour-El Azzi; Houssein Al-Attrache; Camille C Savary; Lydie Humbert; Dominique Rainteau; Christiane Guguen-Guillouzo; André Guillouzo
Journal:  Toxicol Sci       Date:  2014-06-27       Impact factor: 4.849

6.  Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity.

Authors:  Ahmed Ghallab; Reham Hassan; Ute Hofmann; Adrian Friebel; Zaynab Hobloss; Lisa Brackhagen; Brigitte Begher-Tibbe; Maiju Myllys; Joerg Reinders; Nina Overbeck; Selahaddin Sezgin; Sebastian Zühlke; Abdel-Latif Seddek; Walaa Murad; Tim Brecklinghaus; Franziska Kappenberg; Jörg Rahnenführer; Daniela González; Christopher Goldring; Ian M Copple; Rosemarie Marchan; Thomas Longerich; Mihael Vucur; Tom Luedde; Stephan Urban; Ali Canbay; Thomas Schreiter; Michael Trauner; Jephte Y Akakpo; Mojtaba Olyaee; Steven C Curry; Jan-Peter Sowa; Hartmut Jaeschke; Stefan Hoehme; Jan G Hengstler
Journal:  J Hepatol       Date:  2022-02-05       Impact factor: 30.083

7.  Vitamin A supplementation alleviates extrahepatic cholestasis liver injury through Nrf2 activation.

Authors:  Guiyang Wang; Peng Xiu; Fu Li; Cheng Xin; Kewei Li
Journal:  Oxid Med Cell Longev       Date:  2014-07-09       Impact factor: 6.543

8.  Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice.

Authors:  Natalia Nuño-Lámbarri; Mayra Domínguez-Pérez; Anna Baulies-Domenech; Maria J Monte; Jose J G Marin; Patricia Rosales-Cruz; Verónica Souza; Roxana U Miranda; Leticia Bucio; Eduardo E Montalvo-Jave; María Concepción Gutiérrez-Ruiz; Carmen García-Ruiz; José C Fernández-Checa; Luis Enrique Gomez-Quiroz
Journal:  Oxid Med Cell Longev       Date:  2016-08-21       Impact factor: 6.543

9.  Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats.

Authors:  E Tarantola; V Bertone; G Milanesi; E Capelli; A Ferrigno; D Neri; M Vairetti; S Barni; I Freitas
Journal:  Eur J Histochem       Date:  2012-10-08       Impact factor: 3.188

10.  Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress.

Authors:  Yue Long; Xin Dong; Yawei Yuan; Jinqiang Huang; Jiangang Song; Yumin Sun; Zhijie Lu; Liqun Yang; Weifeng Yu
Journal:  J Clin Biochem Nutr       Date:  2015-06-04       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.